{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:41:04Z","timestamp":1792687264942,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52433005"],"award-info":[{"award-number":["52433005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22375226"],"award-info":[{"award-number":["22375226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32261143727"],"award-info":[{"award-number":["32261143727"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jconrel.2025.113892","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T01:58:35Z","timestamp":1748224715000},"page":"113892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Tertiary amine N-oxide zwitterionic lipids facilitate muscle-selective mRNA vaccine delivery for enhancing cDC1-mediated antitumor efficacy"],"prefix":"10.1016","volume":"384","author":[{"given":"Haihong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueer","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guotao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zepeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113892_bb0005","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2025.113892_bb0010","doi-asserted-by":"crossref","first-page":"E1941","DOI":"10.1073\/pnas.1619653114","article-title":"Systemic delivery of factor IX messenger RNA for protein replacement therapy","volume":"114","author":"Ramaswamy","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2025.113892_bb0015","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ymthe.2019.02.019","article-title":"Recent developments in mRNA-based protein supplementation therapy to target lung diseases","volume":"27","author":"Sahu","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.113892_bb0020","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41565-022-01122-3","article-title":"Enhancing CRISPR\/Cas gene editing through modulating cellular mechanical properties for cancer therapy","volume":"17","author":"Zhang","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.113892_bb0025","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/s41588-019-0517-5","article-title":"The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy","volume":"51","author":"Lindeboom","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2025.113892_bb0030","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, N","volume":"383","author":"Polack","year":"2020","journal-title":"Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113892_bb0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113892_bb0040","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113892_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113910","article-title":"The nano delivery systems and applications of mRNA","volume":"227","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.113892_bb0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2025.113892_bb0055","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41392-024-02002-z","article-title":"Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Tar."},{"key":"10.1016\/j.jconrel.2025.113892_bb0060","doi-asserted-by":"crossref","first-page":"e156211","DOI":"10.1172\/JCI156211","article-title":"Messenger RNA vaccines for cancer immunotherapy: progress promotes promise","volume":"132","author":"Huff","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.113892_bb0065","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI81083","article-title":"Beyond antigens and adjuvants: formulating future vaccines","volume":"126","author":"Moyer","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.113892_bb0070","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.apsb.2022.03.011","article-title":"mRNA cancer vaccines: advances, trends and challenges","volume":"12","author":"He","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.113892_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102083","article-title":"mRNA vaccine trafficking and resulting protein expression after intramuscular administration","volume":"35","author":"Hassett","year":"2024","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.jconrel.2025.113892_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113914","article-title":"Vaccine delivery systems toward lymph nodes","volume":"179","author":"Ding","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113892_bb0085","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jhep.2022.03.041","article-title":"Severe de novo liver injury after Moderna vaccination - not always autoimmune hepatitis","volume":"77","author":"Nyein","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.113892_bb0090","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jhep.2022.03.040","article-title":"SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis","volume":"77","author":"Boettler","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.113892_bb0095","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2021.09.031","article-title":"Immune-mediated hepatitis with the moderna vaccine, no longer a coincidence but confirmed","volume":"76","author":"Tun","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.113892_bb0100","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges, and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Tar."},{"key":"10.1016\/j.jconrel.2025.113892_bb0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.113892_bb0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.113892_bb0115","article-title":"Lipid nanoparticles with fine-tuned composition show enhanced colon targeting as a platform for mRNA therapeutics","volume":"12","author":"Rampado","year":"2025","journal-title":"Adv. Sci. (Weinh)."},{"key":"10.1016\/j.jconrel.2025.113892_bb0120","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1021\/jacs.2c10670","article-title":"Iterative design of ionizable lipids for intramuscular mRNA delivery","volume":"145","author":"Tilstra","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.113892_bb0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309472120","article-title":"Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2025.113892_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400327","article-title":"Localization of intramuscular mRNA delivery using deep eutectic-lipid nanocomposites","volume":"13","author":"Curreri","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.113892_bb0135","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1039\/D1BM01454D","article-title":"Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA)","volume":"10","author":"Alvarez-Benedicto","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.113892_bb0140","doi-asserted-by":"crossref","first-page":"21733","DOI":"10.1039\/C9NR09347H","article-title":"On the role of helper lipids in lipid nanoparticle formulations of siRNA","volume":"11","author":"Kulkarni","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2025.113892_bb0145","doi-asserted-by":"crossref","first-page":"eaaw9562","DOI":"10.1126\/sciadv.aaw9562","article-title":"Trimethylamine N-oxide\u2013derived zwitterionic polymers: a new class of ultralow fouling bioinspired materials","volume":"5","author":"Bowen Li","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.113892_bb0150","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41551-021-00701-4","article-title":"Enhanced tumour penetration and prolonged circulation in blood of polyzwitterion\u2013drug conjugates with cell-membrane affinity","volume":"5","author":"Chen","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.113892_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202310401","article-title":"A multidimensional approach to modulating ionizable lipids for high-performing and organ-selective mRNA delivery","volume":"62","author":"He","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jconrel.2025.113892_bb0160","doi-asserted-by":"crossref","first-page":"25698","DOI":"10.1021\/acsami.4c02415","article-title":"Cationic lipid pairs enhance liver-to-lung tropism of lipid nanoparticles for in vivo mRNA delivery","volume":"16","author":"Zeng","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.113892_bb0165","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1002\/pol.20240154","article-title":"Influence of structural variations in polysarcosine functionalized lipids on lipid nanoparticle-mediated mRNA delivery","volume":"62","author":"Tan","year":"2024","journal-title":"J. Polym. Sci."},{"key":"10.1016\/j.jconrel.2025.113892_bb0170","first-page":"1","article-title":"Dendritic cell subsets and locations","volume":"348","author":"Balan","year":"2019","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.113892_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301687","article-title":"Lipid nanoparticle delivery alters the adjuvanticity of the TLR9 agonist CpG by innate immune activation in lymphoid tissue","volume":"12","author":"Zhong","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.113892_bb0180","doi-asserted-by":"crossref","first-page":"eabb9435","DOI":"10.1126\/sciimmunol.abb9435","article-title":"Michael Y Gerner innate cell microenvironments in lymph nodes shape the generation of T cell responses during type I inflammation","volume":"6","author":"Leal","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2025.113892_bb0185","doi-asserted-by":"crossref","first-page":"e001957","DOI":"10.1136\/openhrt-2021-001957","article-title":"Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination","volume":"9","author":"Kornowski","year":"2022","journal-title":"Open Heart."},{"key":"10.1016\/j.jconrel.2025.113892_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100159","article-title":"Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2","volume":"13","author":"Tsilingiris","year":"2022","journal-title":"Metabol. Open"},{"key":"10.1016\/j.jconrel.2025.113892_bb0195","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41565-020-00781-4","article-title":"A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy","volume":"15","author":"Xu","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.113892_bb0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12917-021-02820-1","article-title":"Establishment and evaluation of an indirect ELISA for detection of antibodies to goat Klebsiella pneumonia","volume":"17","author":"Chen","year":"2021","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.jconrel.2025.113892_bb0205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/lam.12070","article-title":"The development of an indirect ELISA for the detection of antibodies to goose parvovirus in blood serum","volume":"57","author":"Fan","year":"2013","journal-title":"Lett. Appl. Microbiol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:53:29Z","timestamp":1779512009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925005127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":41,"alternative-id":["S0168365925005127"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113892","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tertiary amine N-oxide zwitterionic lipids facilitate muscle-selective mRNA vaccine delivery for enhancing cDC1-mediated antitumor efficacy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113892"}}